Anti-ulcer activity of essential oil constituents

Molecules

Volumn 19, Issue 5, 2014, Pages 5717-5747

  De Assis Oliveira, Francisco ^a   Andrade, Luciana Nalone ^b   De Sousa, Élida Batista Vieira ^c   De Sousa, Damião Pergentino ^b,c  

^a FEDERAL UNIVERSITY OF PIAUÍ   (Brazil)

^b FEDERAL UNIVERSITY OF SERGIPE   (Brazil)

^c FEDERAL UNIVERSITY OF PARAÍBA   (Brazil)

Author keywords

Anti inflammatory; Antiulcerogenic; Essential oil; Gastroprotective; Monoterpene; Natural products; Phenylpropanoid; Ulcer

Indexed keywords

ANTIULCER AGENT; ESSENTIAL OIL;

CHEMISTRY; HUMAN; PATHOLOGY; ULCER;

ANTI-ULCER AGENTS; HUMANS; OILS, VOLATILE; ULCER;

EID: 84901476187     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules19055717     Document Type: Review

References (208)

1. Zapata-Colindres J.C.; Zepeda-Gómez S.; Montaño-Loza A.; Vázquez-Ballesteros E.; de Jesús Villalobos J.; Valdovinos-Andraca F. The association of Helicobacter pylori infection and nonsteroidal anti-inflammatory drugs in peptic ulcer disease. Can. J. Gastroenterol. 2006, 20, 277-280.
2. Marcus E.A.; Vagin O.; Tokhtaeva E.; Sachs G.; Scott D.R. Helicobacter pylori impedes acid-induced tightening of gastric epithelial junctions. Am. J. Physiol. Gastrointest. Liver Physiol. 2013, 305, G731-G739.
3. Prabhu V.; Shivani A. An overview of history, pathogenesis and treatment of perforated peptic ulcer disease with evaluation of prognostic scoring in adults. Ann. Med. Health Sci. Res. 2014, 4, 22-29.
4. Klein L.C., Jr.; Gandolfi R.B.; Santin J.R.; Lemos M.; Cechinel-Filho V.; Andrade S.F. Antiulcerogenic activity of extract, fractions, and some compounds obtained from Polygala cyparissias St. Hillaire & Moquin (Poligalaceae). Naunyn-Schmiedeberg's Arch. Pharmacol. 2010, 381, 121-126.
5. Behrman S.W. Management of complicated peptic ulcer disease. Arch. Surg. 2005, 140, 201-208.
6. Lockrey G.; Lima L. Peptic ulcer disease in older people. J. Pharm. Pract. Res. 2011, 41, 58-61.
7. Gadekar R.; Singour P.K.; Chaurasiya P.K.; Pawar R.S.; Patil U.K. A potential of some medicinal plants as an antiulcer agents. Pharmacogn. Rev. 2010, 4, 136-146.
8. Malfertheiner P.; Chan F.K.; Mccoll K.E. Peptic ulcer disease. Lancet 2009, 374, 1449-1461.
9. Awaad A.S.; El-Meligy R.M.; Soliman G.A. Natural products in treatment of ulcerative colitis and peptic ulcer. J. Saudi Chem. Soc. 2013, 17, 101-124.
10. Lakshimi V.; Singh N.; Shrivastva S.; Mishra S.K.; Dharmani P.; Palit G. Gedunin and photogedunin of Xylocarpus granatum show significant anti-secretory effects and protect the gastric mucosa of peptic ulcer in rats. Phytomedicine 2009, 17, 569-574.
11. Sheen E.; Triadafilopoulos G. Adverse effects of long-Term proton pump inhibitor therapy. Dig. Dis. Sci. 2011, 56, 931-950.
12. Zayachkivska O.S.; Konturek S.J.; Drozdowicz D.; Brzozowski T.; Gzhegotsky M.R. Influence of plant-originated gastroprotective and antiulcer substances on gastric mucosal repair. Fiziol. Zh. 2004, 50, 118-127.
13. Schmeda-Hirschmann G.; Yesilada E. Traditional medicine and gastroprotective crude drugs. J. Ethnopharmacol. 2005, 22, 61-66.
14. Edris A.E. Pharmaceutical and therapeutic potentials of essential oils and their individual volatile constituents: A review. Phytother. Res. 2007, 21, 308-323.
15. De Sousa D.P. Medicinal Essential Oils: Chemical, Pharmacological and Therapeutic Aspects, 1st ed.; Nova Science Publishers: New York, NY, USA, 2012; pp. 1-236.
16. Bakkali F.; Averbeck S.; Averbeck D.; Idaomar M. Biological effects of essential oils-A review. Food Chem. Toxicol. 2008, 46, 446-475.
17. Lewis D.A.; Hanson P.J. Anti-ulcer drugs of plant origin. Prog. Med. Chem. 1991, 28, 201-231.
18. Rozza A.L.; Hiruma-Lima C.A.; Takahira R.K.; Padovani C.R.; Pellizzon C.H. Effect of menthol in experimentally induced ulcers: Pathways of gastroprotection. Chem. Biol. Interact. 2013, 206, 272-278.
19. Shah K.; Shrivastava S.; Mishra P. Evaluation of mefenamic acid mutual prodrugs. Med. Chem. Res. 2013, 22, 70-77.
20. Kamatou G.P.; Vermaak I.; Viljoen A.M.; Lawrence B.M. Menthol: A simple monoterpene with remarkable biological properties. Phytochemistry 2013, 96, 15-25.
21. Shanbhag V.R.; Rider A.M.; Gokhale R.; Harpalanai A.; Dick R.M. Ester and amide prodrugs of ibuprofen and naproxen: Synthesis, anti-inflammatory activity and gastrointestinal toxicity. J. Pharm. Sci. 1992, 81, 149-154.
22. Khan M.S.Y.; Akhter M. Synthesis, pharmacological activity and hydrolytic behavior of glyceride prodrugs of ibuprofen. Eur. J. Med. Chem. 2005, 40, 371-376.
23. Redasani V.K.; Sanjay B.B. Synthesis and evaluation of mutual prodrugs of ibuprofen with menthol, thymol and eugenol. Eur. J. Med. Chem. 2012, 56, 134-138.
24. Santos F.A.; Rao V.S.N. 1, 8-Cineol, a food flavoring agent, prevents ethanol-induced gastric injury in rats. Digest. Dis. Sci. 2001, 46, 331-337.
25. Vernin G.A.; Parkanyi C.; Cozzolino F.; Fellous R. GC/MS analysis of the volatile constituents of Corymbia citriodora Hook. from Réunion Island. J. Essent. Oil Res. 2004, 16, 560-565.
26. Paik S.Y.; Kok K.H.; Beak S.M.; Paek S.H.; Kim J.A. The essential oils from Zanthoxylum schinifolium pericarp induce apoptosis of HepG2 human hepatoma cells through increased production of reactive oxygen species. Biol. Pharm. Bull. 2005, 28, 802-807.
27. Serra S.; Brenna E.; Fuganti C.; Maggioni F. Lipase-catalyzed resolution of p-menthan-3-ols monoterpenes: Preparation of the enantiomer-enriched forms of menthol, isopulegol, trans-And cis-piperitol, and cis-isopiperitenol. Tetrahedron Asymmetry 2003, 14, 3313-3319.
28. Bhatia S.P.; McGinty D.; Letizia C.S.; Api A.M. Fragrance material review on alpha-bisabolol. Food Chem. Toxicol. 2008, 46, 72-76.
29. Bhatia S.P.; McGinty D.; Letizia C.S.; Api A.M. Fragrance material review on isopulegol. Food Chem. Toxicol.2008, 46, 185-189.
30. Spindler P.; Madsen C. Subchronic toxicity study of peppermint oil in rats. Toxicol. Lett. 1992, 62, 215-220.
31. Silva M.I.G.; Moura B.A.; Neto M.R.A.; Tomé A.R.; Rocha N.F.M.; Carvalho A.M.R; Macêdo D.S.; Vasconcelos S.M.M.; Sousa D.P.; Viana G.S.B.; et al. Gastroprotective activity of isopulegol on experimentally induced gastric lesions in mice: Investigation of possible mechanisms of action. Naunyn-Schmiedeberg's Arch. Pharmacol. 2009, 380, 233-245.
32. Robert A. Cytoprotection by prostaglandins. Gastroenterology 1979, 77, 761-767.
33. Das S.K.; Vasudevan D.M. Alcohol-induced oxidative stress. Life Sci. 2007, 81, 177-187.
34. Szabo S. Mechanisms of Mucosal Injury in the Stomach and Duodenum: Time-sequence Analysis of Morphologic, Functional, Biochemical and Histochemical Studies Scandinavian. J. Gastroenterol. 1987, 22, 21-28.
35. Nguemfo E.L.; Dimo T.; Dongmo A.B.; Azebaze A.G.; Alaoui K.; Asongalem A.E.; Cherrah Y.; Kamtchouing P. Anti-oxidative and anti-inflammatory activities of some isolated constituents from the stem bark of Allanblackia monticola Staner L.C (Guttiferae). Inflammopharmacology 2009, 17, 37-41.
36. Miller T.A. Protective effects of prostaglandins against gastric mucosal damage: Current knowledge and proposed mechanisms. Am. J. Physiol. 1983, 245, 601-623.
37. Rainsford K.D. Structure-Activity relationships of non-steroid anti-inflammatory drug gastric ulcerogenic activity. Agents Actions 1978, 8, 587-605.
38. Wallace J.L. Nitric oxide, aspirin-Triggered lipoxins and NO aspirin in gastric protection. Inflamm. Allergy Drug Targets 2006, 5, 133-137.
39. Peskar B.M.; Ehrlich K.; Peskar B.M. Role of ATP-Sensitive Potassium Channels in Prostaglandin-Mediated Gastroprotection in the Rat. J. Pharmacol. Exp. Ther. 2002, 301, 969-974.
40. Sayyah M.; Nadjafnia L.; Kamalinejad M. Anticonvulsant activity and chemical composition of Artemisia dracunculus L. essential oil. J. Ethnopharmacol. 2004, 94, 283-287.
41. Meral G.E.; Konyalioglu S.; Ozturk B. Essential oil composition and antioxidant activity of endemic Ziziphora taurica subsp. cleonioides. Fitoter 2002, 73, 716-718.
42. Siani A.C.; Garrido I.S.; Monteiro S.S.; Carvalho E.S.; Ramos M.F.S. Protium icicariba as a source of volatile essences. Biochem. Syst. Ecol. 2004, 32, 477-489.
43. Amaral M.P.M.; Braga F.A.V.; Passos F.F.B.; Almeida F.R.C.; Oliveira R.C.M.; Carvalho A.A.; Arruda D.; Alexandri F.D.; Katzin A.; Uliana S. Antileishmanial activity of the terpene Nerolidol. Clin. Exp. Pharmacol. Physiol. 2005, 49, 1679-1687.
44. Sun J. D-Limonene: Safety and clinical applications. Altern. Med. Rev. 2007, 12, 259-264.
45. Moraes T.M.; Kushima H.; Moleiro F.C.; Santos R.C.; Rocha L.R.M.; Marques M.O.; Vilegas W.; Hiruma-Lima C.A. Effects of limonene and essential oil from Citrus aurantium on gastric mucosa: Role of prostaglandins and gastric mucus secretion. Chem. Biol. Interact. 2009, 180, 499-505.
46. Rozza A.L.; Moraes T.M.; Kushima H.; Tanimoto A.; Marques M.O.M.; Bauab T.M.; Hiruma-Lima C.A.; Pellizzon C.H. Gastroprotective mechanisms of Citrus lemon (Rutaceae) essential oil and its majority compounds limonene and β-pinene: Involvement of heat-shock protein-70, vasoactive intestinal peptide, glutathione, sulfhydryl compounds, nitric oxide and prostaglandin E2. Chem. Biol. Interact. 2011, 189, 82-89.
47. Baananou S.; Bouftira I.; Mahmoud A.; Boukef K.; Marongiu B.; Boughattas N.A. Antiulcerogenic and antibacterial activities of Apium graveolens essential oil and extract. Nat. Prod. Res. 2013, 27, 1075-1083.
48. Al Moutaery A.R. Protective effect of ketoconazole against experimentally induced gastric ulcers in rats. Res. Commun. Mol. Pathol. Pharmacol. 2003, 113, 5-23.
49. Tunçel N.; Tunçel M.; Aboul-Enein H.Y. Effects of the vasoactive intestinal peptide on stress-induced mucosal ulcers and modulation of methylation of histamine in gastric tissue of the rats. Il Farmaco 2003, 58, 449-454.
50. Szabo S.; Vattay P. Experimental gastric and duodenal ulcers. Advances in pathogenesis. Gastroenterol. Clin. N. Am. 1990, 19, 67-85.
51. Muhammad J.S.; Sugiyama T.; Zaidi S.F. Gastric pathophysiological ins and outs of helicobacter pylori: A review. J. Pak. Med. Assoc. 2013, 63, 1528-1533.
52. Alarcon T.; Domingo D.; Lopez-Brea M. Antibiotic resistance problems with Helicobacter pylori. Int. J. Antimicrob. Agents 1999, 12, 19-26.
53. Mitscher L.A.; Drake S.; Gollapudi S.R.; Okwute K. Model look at folkloric use of anti-infective agents. J. Nat. Prod. 1987, 50, 1025-1040.
54. Sanguinetti E.E. Plantas Que Curam, 2nd ed.; Editora Rígel: Porto Alegre, RS, Brazil, 1989; p. 208.
55. Bandhopadhyay U.; Biswas K.; Chatterjee R.; Kumar Ganguly I.C.C.; Bhattacharya K.; Banerjee R. Gastroprotective effect of Neem (Azadiracta indica) bark extract: Possible involvement of H+K+ATPase inhibition and scavenging of hydroxyl radical. Life Sci. 2002, 71, 2845-2865.
56. Martin G.R.; Wallace J.L. Gastrointestinal inflammation: A central component of mucosal defense and repair. Exp. Biol. Med. 2006, 231, 130-137.
57. Rainsford K.D. The effect of 5-lipoxygenase inhibitors and leukotriene antagonists on the development of gastric lesions induced by non steroidal anti-inflammatory drugs in mice. Agents Action 1987, 21, 316-319.
58. Glavin G.B.; Szabo S. Experimental gastric mucosal injury, laboratory models reveal mechanism of pathogenesis and new therapeutic strategies. FASEB J. 1992, 6, 825-831.
59. Breggia M.E.; Miguenz M.; Silberman P.E.; Laudisi C.; Lemberg A.; Filinger E. Fármacos usados para el Control de la Acidez Gástrica y el Tratamiento de la Úlcera Péptica. Acta Farmacéut. Bonaer. 2000, 19, 133-142. (In Spanish).
60. Flemstrom G.; Isenberg J.I. Gastroduodenal mucosal alkaline secretion and mucosal protection. News Physiol. Sci. 2001, 16, 23-28.
61. Tariq M.; Khan H.A.; Elfaki I.; Arshaduddin M.; Al Moutaery M.; Al Rayes H.; Al Swailam R. Gastric antisecretory and antiulcer effects of simvastatin in rats. J. Gastroenterol. Hepatol. 2007, 22, 2316-2323.
62. De Vincenzi M.; Silano M.; de Vincenzi A.; Maialetti F.; Scazzocchio B. Safety data review: Constituents of aromatic plants: Eucalyptol. Fitoterapia 2002, 73, 269-275.
63. Kirsch F.; Beauchamp J.; Buettner A. Time-dependent aroma changes in breast milk after oral intake of a pharmacological preparation containing 1, 8-cineole. J. Clin. Nutr. 2012, 31, 682-692.
64. Pattnaick S.; Subramanyam V.R.; Bapaji M.; Kole C.R. Antibacterial and antifungal activity of aromatic constituents of essential oils. Microbios 1997, 89, 39-46.
65. Peskar B.M.; Lange K.; Hoppe U.; Peskar B.A. Ethanol stimulates formation of leukotriene C4 in ratgastric mucosa. Prostaglandins 1986, 31, 283-293.
66. Alarcon L.L.C.; Martin M.J.; Marhuenda E. Gastric anti-ulcer activity of silymarin, a lipoxygenase inhibitor, in rats. J. Pharm. Pharmacol. 1992, 44, 929-931.
67. Boughton-Smith N.K.; Bhatia S.P.; McGinty D.; Letiziam C.S.; Api A.M. Involvement of leukotrienes in acute gastric damage. Methods Find. Exp. Clin. Pharmacol. 1989, 11, 53-59.
68. Juergens U.R.; Stöber M.; Vetter H. Inhibition of cytokine production and arachidonic acid metabolism by eucalyptol (1.8-cineole) in human blood monocytes in vitro. Eur. J. Med. Res. 1998, 3, 508-510.
69. Santos F.A.; Silva R.M.; Campos A.R.; de Araújo R.P.; Lima Júnior R.C.; Rao V.S. 1, 8-cineole (eucalyptol), a monoterpene oxide attenuates the colonic damage in rats on acute TNBS-colitis. Food Chem. Toxicol. 2004, 42, 579-584.
70. Kumar A.; Singh V.; Chaudhary A.K. Gastric antisecretory and antiulcer activities of Cedrus deodara (Roxb.) Loud. in Wistar rats. J. Ethnopharmacol. 2011, 134, 294-297.
71. Houghton P.J.; Zarka R.; de las Heras B.; Hoult J.R. Fixed oil of Nigella sativa and derived thymoquinone inhibit eicosanoid generation in leukocytes and membrane lipid peroxidation. Planta Med. 1995, 61, 33-36.
72. Kruk I.; Michalska T.; Lichszteld K.; Køadna A.; Aboul-Enein H.Y. The effect of thymol and its derivatives on reactions generating reactive oxygen species. Chemosphere 2000, 41, 1059-1064.
73. El-Abhar H.S.; Abdallah D.M.; Saleh S. Gastroprotective activity of Nigella sativa oil and its constituent, thymoquinone, against gastric mucosal injury induced by ischaemia/reperfusion in rats. J. Ethnopharmacol. 2003, 84, 251-258.
74. Yoshikawa T.; Naito Y.; Ueda S.; Ichikawa H.; Takahashi S.; Yasuda M.; Kondo M. Ischemia-reperfusion injury and free radical involvement in gastric mucosal disorders. Adv. Exp. Med. Biol. 1992, 316, 231-238.
75. Arslan S.O.; Gelir T.E.; Armutcu F.; Coskun O.; Gurel A.; Sayan H.; Celik I.L. The protective effect of thymoquinone on ethanol-induced acute gastric damage in the rat. Nutr. Res. 2005, 25, 673-680.
76. Kanter M.; Demir H.; Karakaya C.; Ozbek H. Gastroprotective activity of Nigella sativa L oil and its constituent, thymoquinone against acute alcohol-induced gastric mucosal injury in rats. World J. Gastroenterol. 2005, 11, 6662-6666.
77. Ohta Y.; Kobayashi T.; Ishiguro I. Participation of xanthine-xanthine oxidase system and neutrophils in development of acute gastric mucosal lesions in rats with a single treatment of compound 48/80, a mast cell degranulator. Dig. Dis. Sci. 1999, 44, 1865-1874.
78. Ohta Y.; Kobayashi T.; Imai Y.; Inui K.; Yoshino J.; Nakazawa S. Effect of oral Vitamin E administration on acute gastric mucosal lesion progression in rats treated with compound 48/80, a mast cell degranulator. Biol. Pharm. Bull. 2006, 29, 675-683.
79. Singh S.; Khajuria A.; Taneja S.C.; Khajuria R.K.; Singh J.; Johri R.K.; Qazi G.N. The gastric ulcer protective effect of boswellic acids, a leukotriene inhibitor from Boswellia serrata, in rats. Phytomedicine 2008, 15, 408-415.
80. Kanter M.; Coskun O.; Uysal H. The antioxidative and antihistaminic effect of Nigella sativa and its major constituent, thymoquinone on ethanol-induced gastric mucosal damage. Arch. Toxicol. 2006, 80, 217-224.
81. Chakravarty N. Inhibition of histamine release from mast cells by nigellone. Ann. Allergy 1993, 70, 237-242.
82. Magdy M.A.; Hanan E.A.; Nabila E.M. Thymoquinone: Novel gastroprotective mechanisms. Eur. J. Pharmacol. 2012, 697, 126-131.
83. Mansour M.A.; Nagi M.N.; El-Khatib A.S.; Al-Bekairi A.M. Effects of thymoquinone on antioxidant enzyme activities, lipid peroxidation and DT-diaphorase in different tissues of mice: A possible mechanism of action. Cell. Biochem. Funct. 2002, 20, 143-151.
84. Al-Ali A.; Alkhawajah A.A.; Randhawa M.A.; Shaikh N.A. Oral and intraperitoneal LD50 of thymoquinone, an active principle of Nigella sativa, in mice and rats. J. Ayub Med. Coll. Abbottabad 2008, 20, 25-27.
85. Kacem R.; Meraihi Z. Effects of essential oil extracted from Nigella sativa (L.) seeds and its main components on human neutrophil elastase activity. Yakugaku Zasshi 2006, 126, 301-305.
86. De Vicenzi M.; Stammati A.; de Vicenzi A.; Silano M. Constituents of aromatic plants: Carvacrol. Fitoterapia 2004, 75, 801-804.
87. Jenner P.M.; Hagan E.C.; Taylor J.M.; Cook E.L.; Fitzhugh O.G. Food flavourings and compounds of related structure I. Acute oral toxicity. Food Cosmet. Toxicol. 1964, 2, 327-343.
88. Fenaroli G. Fenaroli's Handbook of Flavor Ingredients, 4th ed.; CRC: Boca Raton, FL, USA, 2001.
89. Landa P.; Kokoska L.; Pribylova M.; Vanek T.; Marsik P. In vitro anti-inflammatory activity of carvacrol: Inhibitory effect on COX-2 catalyzed prostaglandin E(2) biosynthesis. Arch. Pharmacal. Res. 2009, 32, 75-78.
90. Guimarães A.G.; Oliveira G.F.; Melo M.S.; Cavalcanti S.C.; Antoniolli A.R.; Bonjardim L.R.; Silva F.A.; Santos J.P.; Rocha R.F.; Moreira J.C.; et al. Bioassay-guided evaluation of antioxidant and antinociceptive activities of carvacrol. Basic Clin. Pharmacol. Toxicol. 2010, 107, 949-957.
91. Silva F.V.; Guimaraes A.G.; Silva E.R.S.; Sousa-Neto B.P.; Machado F.D.F.; Quintans-Junior L.J.; Arcanjo D.D.R.; Oliveira F.A.; Oliveira R.C.M. Anti-inflammatory and anti-ulcer activities of carvacrol, a monoterpene present in the essential oil of Oregano. J. Med. Food 2012, 15, 984-991.
92. Okabe S.; Amagase S. An overview of acetic acid ulcer models: The history and state of the art of peptic ulcer research. Biol. Pharm. Bull. 2005, 28, 1321-1341.
93. Kobayashi T.; Ohta Y.; Yoshino J.; Nakazawa S. Teprenone promotes the healing of acetic acid-induced chronic gastric ulcers in rats by inhibiting neutrophil infiltration and lipid peroxidation in ulcerated gastric tissues. Pharmacol. Res. 2001, 43, 23-30.
94. Shahin M.; Konturek P.W.; Pohle T.; Schuppan D.; Herbst H.; Domschke W. Remodeling of extracellular matrix in gastric ulceration. Microsc. Res. Tech. 2001, 5, 396-408.
95. Oliveira I.S.; Silva F.V.; Viana A.F.S.C.; Santos M.R.V.; Quintans-Júnior L.J.; Martins M.C.C.; Nunes P.H.M.; Oliveira F.A.; Oliveira R.C.M. Gastroprotective activity of carvacrol on experimentally induced gastric lesions in rodents. Naunyn-Schmiedeberg's Arch. Pharmacol. 2012, 385, 899-908.
96. Hotta M.; Nakata R.; Katsukawa M.; Hori K.; Takahashi S.; Inoue H. Carvacrol, a component of thyme oil, activates PPARalpha and gamma and suppresses COX-2 expression. J. Lipid Res. 2010, 51, 132-139.
97. Raina V.K.; Kumar A.; Srivastava S.K.; Syamsundar K.V.; Kahol A.P. Essential oil composition of "kewda" (Pandanus odoratissimus) from India. Flavour. Frag. J. 2004, 19, 434-436.
98. Harrathi J.; Hosni K.; Karray-Bouraoui N.; Attia H.; Marzouk B.; Magné C.; Lachaâl M. Effect of salt stress on growth, fatty acids and essential oils in safflower (Carthamus tinctorius L.). Naunyn-Schmiedeberg's Arch. Pharmacol. 2012, 34, 129-137.
99. Choi Y.J.; Sim C.; Choi H.K.; Lee S.H.; Lee B.H. α-Terpineol induces fatty liver in mice mediated by the AMP-Activated kinase and sterol response element binding protein pathway. Food Chem. Toxicol. 2013, 55, 129-136.
100. De Sousa D.P.; Quintans J.L.; Almeida R.N. Evaluation of the Anticonvulsant Activity of alfa-Terpineol. Pharm. Biol. 2007, 45, 69-70.
101. Quintans-Júnior L.J.; Oliveira M.G.B.; Santana M.F.; Santgana M.T.; Guimarγes A.G.; Siqueira J.S.; de Sousa D.P.; Almeida R.N. α-Terpineol reduces nociceptive behavior in mice. Pharm. Biol. 2011, 49, 583-586.
102. Ribeiro T.P.; Porto D.L.; Menezes C.P.; Antunes A.A.; Silva D.F.; de Sousa D.P.; Nakao L.S.; Braga V.A.; Medeiros I.A. Unravelling the cardiovascular effects induced by alpha-Terpineol: A role for the nitric oxide-cGMP pathway. Clin. Exp. Pharmacol. Physiol. 2010, 37, 811-816.
103. Souza R.H.L.; Cardoso M.S.P.; Menezes C.T.; Silva J.P.; de Sousa D.P.; Batista J.S. Gastroprotective activity of α-Terpineol in two experimental models of gastric ulcer in rats. Daru 2011, 19, 277-281.
104. Paisooksantivatana S.; Bua-in Y. Essential oil and antioxidant activity of Cassumunar Ginger (Zingiberaceae: Zingiber montanum (Koenig) Link ex Dietr.) collected from various parts of Thailand. Kasetsart J. Nat. Sci. 2009, 43, 467-475.
105. Sukatta U.; Rugthaworn P.; Punjee P.; Chidchenchey S.; Keeratinijakal V. Chemical composition and physical properties of oil from Plai (Zingiber cassumunar Roxb.) obtained by hydro distillation and hexane extraction. Kasetsart J. Nat. Sci. 2009, 43, 212-217.
106. Pazyar N.; Yaghoobi R.; Bagheran N.; Kazerouni A. A review of applications of tea tree oil in dermatology. Int. J. Dermatol. 2013, 52, 784-790.
107. Hamrouni S.I.; Maamouri E.; Chahed T.; Aidi W.W.; Kchouk M.E.; Marzouk B. Effect of growth stage on the content and composition of the essential oil and phenolic fraction of sweet marjoram (Origanum majorana L.). Ind. Crop. Prod. 2009, 30, 395-402.
108. Australian Government. Australian Pesticides and Veterinary Medicines Authority. Available online: http://www.apvma.gov.au/advice-summaries/45928.rtf (accessed on 29 April 2014).
109. Ninomiya K.; Hayama K.; Ishijima S.A.; Maruyama N.; Irie H.; Kurihara J.; Abe S. Suppression of inflammatory reactions by terpinen-4-ol, a main constituent of tea tree oil, in a murine model of oral candidiasis and its suppressive activity to cytokine production of macrophages in vitro. Biol. Pharm. Bull. 2013, 36, 838-844.
110. Lahlou S.; Galindo C.A.B.; Leal-Cardoso J.H.; Fonteles M.C.; Duarte G.P. Cardiovascular effects of the essential oil of Alpinia zerumbet leaves and its main constituent, terpinen-4-ol, in rats: Role of the autonomic nervous system. Planta Med. 2002, 68, 1097-1102.
111. Matsunaga T.; Hasegawa C.; Kawasuji T.; Suzuki H.; Saito H.; Sagioka T.; Takahashi R.; Tsukamoto H.; Morikawa T.; Akiyama T. Isolation of the antiulcer compound in essential oil from the leaves of Cryptomeria japonica. Biol. Pharm. Bull. 2000, 23, 595-598.
112. Iacobellis N.S.; Lo Cantore P.; Capasso F.; Senatore F. Antibacterial activity of Cuminum cyminum L. and Carum carvi L. essential oils. J. Agric. Food Chem. 2005, 53, 57-61.
113. Jirovetz L.; Buchbauer G.; Shafi P.M.; Abraham G.T. Analysis of the essential oil of the roots of the medicinal plant Kaempferia galanga L. (Zingiberaceae) from South India. Acta Pharm. Turc. 2001, 43, 107-110.
114. Sousa D.P.; Nóbrega F.F.F.; Claudino F.S.; Almeida R.N.; Leite J.R.; Mattei R. Pharmacological effects of the monoterpene α, β-epoxy-carvone in mice. Braz. J. Pharmacogn. 2007, 17, 170-175.
115. Almeida R.N.; Sousa D.P.; Nóbrega F.F.F.; Claudino F.S.; Araújo D.A.M.; Leite J.R.; Mattei R. Anticonvulsant effect of a natural compound α, β-epoxy-carvone and its action on the nerve excitability. Neurosci. Lett. 2008, 443, 51-55.
116. Arruda T.A.; Antunes R.M.P.; Catão R.M.R.; Lima E.O.; Sousa D.P.; Nunes X.P.; Pereira M.S.V.; Barbosa-Filho J.M.; da Cunha E.V.L. Preliminary study of the antimicrobial activity of Mentha. x villosa Hudson essential oil, rotundifolone and its analogues. Rev. Bras. Farmacogn. 2006, 16, 307-311.
117. Rocha M.L.; Oliveira L.E.G.; Santos C.M.P.; Sousa D.P.; Almeida R.N.; Araujo D.A.M. Antinociceptive and anti-inflammatory effects of the monoterpene α-β-epoxy-carvone in mice. J. Nat. Med. 2013, 67, 743-749.
118. Siqueira B.P.J.; Menezes C.T.; Silva J.P.; Sousa D.P.; Batista J.S. Antiulcer effect of epoxy-carvone. Braz. J. Pharmacogn 2012, 22, 144-149.
119. Belsito D.; Bickers D.; Bruze M.; Calow P.; Greim H.; Hanifin J.M.; Rogers A.E.; Saurat J.H.; Sipes I.G.; Tagami H. A toxicologic and dermatologic assessment of cyclic and non-cyclic terpene alcohols when used as fragrance ingredientes (Review). Food Chem. Toxicol. 2008, 46, 1-71.
120. Bhatia S.P.; Letizia S.C.; Api A.M. Fragrance material review on elemol. Food Chem. Toxicol. 2008, 46, 147-148.
121. Paluch G.; Grodnitzky J.; Bartholomay L.; Coats J. Quantitative structure-Activity relationship of botanical sesquiterpenes: Spatial and contact repellency to the yellow fever mosquito, Aedes aegypti. J. Agric. Food Chem. 2009, 57, 7618-7625.
122. Wedge D.E.; Tabanca N.; Sampson B.J.; Werle C.; Demirci B. Baser K.H.; Nan P.; Duan J.; Liu Z. Antifungal and insecticidal activity of two Juniperus essential oils. Nat. Prod. Commun. 2009, 4, 123-127.
123. Vila R.; Mundina M.; Muschietti L.; Priestap H.A.; Bandoni A.L.; Adzet T.; Canigueral S. Volatile constituents of leaves, roots and stems from Aristolochia elegans. Phytochemistry 1997, 46, 1127-1129.
124. Péres V.F.; Moura D.J.; Sperotto A.R.; Damasceno F.C.; Caramão E.B.; Zini C.A.; Saffi J. Chemical composition and cytotoxic, mutagenic and genotoxic activities of the essential oil from Piper gaudichaudianum Kunth leaves. Food Chem. Toxicol. 2009, 47, 2389-2395.
125. Klopell F.C.; Lemos M.; Sousa J.P.; Comunello E.; Maistro E.L.; Bastos J.K.; de Andrade S.F. Nerolidol, an antiulcer constituent from the essential oil of Baccharis dracunculifolia DC (Asteraceae). Z. Naturforsch. C 2007, 62, 537-542.
126. Massignani J.J.; Lemos M.; Maistro E.L.; Schaphauser H.P.; Jorge R.F.; Sousa J.P.B.; Bastos J.K.; Andrade S.F. Antiulcerogenic Activity of the Essential Oil of Baccharis dracunculifolia on Different Experimental Models in Rats. Phytother. Res. 2009, 23, 1355-1360.
127. Kim S.; Jung E.; Kim J.H.; Park Y.O.; Lee J.; Park D. Inhibitory effects of (-)-α-bisabolol on LPS-induced inflammatory response in RAW264.7 macrophages. Food Chem. Toxicol. 2011, 49, 2580-2585.
128. Andersen F.A. Final report on the safety assessment of Bisabolol. Int. J. Toxicol. 1999, 18, 33-44.
129. Avonto C.; Wang M.; Chittiboyina A.G.; Avula B.; Zhao J.; Khan I.A. Hydroxylated bisabolol oxides: Evidence for secondary oxidative metabolism in Matricaria chamomilla. J. Nat. Prod. 2013, 76, 1848-1853.
130. Vila R.; Santana A.I.; Perez-Roses R.; Valderrama A.; Castelli M.V.; Mendonca S.; Zacchino S.; Gupta M.P.; Canigueral S. Composition and biological activity of the essential oil from leaves of Plinia cerrocampanensis, a new source of alpha-bisabolol. Bioresour. Technol. 2010, 101, 2510-2514.
131. Leite G.O.; Leite L.H.I.; Sampaio R.S.; Araruna M.K.A.; Menezes I.R.A.; Costa J.G.M.; Campos A.R. (-)-α-Bisabolol attenuates visceral nociception and inflammation in mice. Fitoterapia 2011, 82, 208-211.
132. Silva A.P.; Martini M.V.; Oliveira C.M.; Cunha S.; Carvalho J.E.; Ruiz A.L.; Silva C.C. Antitumor activity of (-)-Alpha-bisabolol-based thiosemicarbazones against human tumor cell lines. Eur. J. Med. Chem. 2010, 45, 2987-2993.
133. Bezerra S.B.; Leal L.K.A.M.; Nogueira N.A.P.; Campos A.R. Bisabolol-induced gastroprotection against acute gastric lesions: Role of prostaglandins, nitric oxide, and KATP+ Channels. J. Med. Food 2009, 12, 1403-1406.
134. Rocha N.F.M.; Venancio E.T.; Moura B.A.; Silva M.I.G.; Aquino Neto M.F.; Rios V.E.R.; Sousa D.P.; Vasconcelos S.M.M.; Fonteles M.M.F.; Sousa F.C.F. Gastroprotection of (-)-α-bisabolol on acute gastric mucosal lesions in mice: The possible involved pharmacological mechanisms. Fundam.Clin. Pharmacol. 2010, 24, 63-71.
135. Halici M.; Odabasoglu F.; Suleyman H.; Cakir A.; Aslan A.; Bayir Y. Effects of water extract of Usnea longissima on antioxidant enzyme activity and mucosal damage caused by indomethacin in rats. Phytomedicine 2005, 12, 656-662.
136. Rocha N.F.M.; Rios E.R.V.; Carvalho A.M.R.; Cerqueira G.S.; Lopes A.A.; Leal L.K.A.M.; Dias M.L.; Sousa D.P.; Sousa C.F.C. Anti-nociceptive and anti-inflammatory activities of (-)-α-bisabolol in rodents. Naunyn-Schmiedeberg's Arch. Pharmacol. 2011, 384, 525-533.
137. Dursun H.; Bilici M.; Albayrak F.; Ozturk C.; Saglam M.B.; Alp H.H.; Suleyman H. Antiulcer activity of fluvoxamine in rats and its effect on oxidant and antioxidant parameters in stomach tissue. BMC Gastroenterol. 2009, 9, 36.
138. Sannomiya M.; Fonseca V.B.; da Silva M.A.; Rocha L.R.; Dos Santos L.C.; Hiruma-Lima C.A.; Souza Brito A.R.; Vilegas W. Flavonoids and antiulcerogenic activity from Byrsonima crassa leaves extracts. J. Ethnopharmacol. 2005, 97, 1-6.
139. Mates J.M.; Perez-Gomez C.; Castro I.N. Antioxidant enzymes and human diseases. Clin. Biochem. 1999, 32, 595-603.
140. Yoshikawa T.; Minamiyama Y.; Ichikawa H.; Takahashi S.; Naito Y.; Kondo M. Role of lipid peroxidation and antioxidants in gastric mucosal injury induced by the hypoxanthine-x anthine oxidase system in rats. Free Radic. Bio. Med. 1997, 23, 243-250.
141. Huang X.R.; Chun Hui C.W.; Chen Y.X. Macrophage migration inhibitory factor is an important mediator in the pathogenesis of gastric inflammation in rats. Gastroenterology 2001, 121, 619-630.
142. Chainy G.B.; Manna S.K.; Chaturvedi M.M.; Aggarwal B.B. Anethole blocks both early and late cellular responses transduced by tumor necrosis factor: Effect on NF-kappaB, AP-1, JNK, MAPKK and apoptosis. Oncogene 2000, 19, 2943-2950.
143. Ghelardini C.; Galeotti N.; Mazzanti G. Local anaesthetic activity of monoterpenes and phenylpropanes of essential oils. Planta Med. 2001, 67, 564-566.
144. Freire R.S.; Morais S.M.; Catunda-Junior F.E.A.; Pinheiro D.C.S.N. Synthesis and antioxidant, anti-inflammatory and gastroprotector activities of anethole and related compounds. Bioorg. Med. Chem. 2005, 13, 4353-4358.
145. Miller H.E. A simplified method for the evaluation of antioxidant. J. Am. Oil Chem. Soc. 1971, 48, 91.
146. Craveiro A.A.; Andrade C.H.; Matos F.J.; Alencar J.W.; Dantas T.N. Fixed and volatile constituents of Croton aff. nepetifolius. J. Nat.Prod. 1980, 43, 756-757.
147. Coelho-de-Souza A.N.; Criddle D.N.; Leal-Cardoso J.H. Selective and modulatory effects of the essential oil of Croton zehntneri on isolated smooth muscle preparations of the guinea pig. Phytother. Res. 1998, 12, 189-194.
148. Coelho-De-Souza A.N.; Lahlou S.; Barreto J.E.F., Yum M.E.M.; Oliveira A.C.; Oliveira H.D.; Celedonio N.R.; Feitosa R.G.R.; Duarte G.P.; Santos C.F.; et al. Essential oil of Croton zehntneri and its major constituent anethole display gastroprotective effect by increasing the surface mucous layer. Fundam.Clin. Pharmacol. 2013, 27, 288-298.
149. Hagan E.C.; Jenner P.M.; Jones W.I.; Fitzhugh O.G.; Long E.L.; Brouwer J.G.; Dwebb W.K. Toxic properties of compounds related to safrole. Toxic. Appl. Pharmac. 1965, 7, 18-24.
150. Taylor J.M.; Jenner P.M.; Jones W.I. A comparison of the toxicity of some allyl, propenyl and propyl compounds in the rat. Toxic. Appl. Pharm. 1964, 2, 378.
151. Truhaut R.; Le Bourhis B.; Attia M.; Glomot R.; Newman J.; Caldwell J. Chronic toxicity/carcinogenicity study of trans-Anethole in rats. Food Chem. Toxicol. 1989, 27, 11-20.
152. Cai L.; Wu C.D. Compounds from Syzygium aromaticum possessing growth inhibitory activity against oral pathogens. J. Nat. Prod. 1996, 59, 987-990.
153. Sober H.A.; Hollander F.; Sober E.K. Toxicity of eugenol determination of LD50 on rats. Exp. Biol. Med. 1950, 73, 148-151.
154. Sax N.I. Dangerous Properties of Industrial Materials, 11th ed.; Lewis R.J., Sr., Ed.; Wiley-Interscience; Wiley & Sons, Inc.: Hoboken, NJ, USA, 2004; p. 1735, doi:10.1002/0471701343.
155. Kim H.M.; Lee E.H.; Kim C.Y.; Chung J.G.; Kim S.H.; Lim J.P.; Shin T.Y. Antianaphylactic properties of eugenol. Pharmacol. Res. 1997, 36, 475-680.
156. Sharma J.N.; Srivastava K.C.; Gan E.K. Suppressive effects of eugenol and ginger oil on arthritic rats. Pharmacology 1994, 49, 314-318.
157. Santin J.R.; Lemos M.; Klein-Júnior L.C.; Machado I.D.; Costa P.; Oliveira A.P.; Tilia C.; Souza J.P.; Sousa J.P.B.; Bastos J.K.; et al. Gastroprotective activity of essential oil of the Syzygium aromaticum and its major component eugenol in different animal models. Naunyn-Schmiedeberg's Arch. Pharmacol. 2011, 383, 149-158.
158. Hiruma-Lima C.A.; Santos L.C.; Kushima H.; Pellizzon C.H.; Silveira G.G.; Vasconcelos P.C.P.; Vilegas W.; Souza Brito A.R.M. Qualea grandiflora, a Brazilian "Cerrado" medicinal plant presents an important antiulcer activity. J. Ethnopharmacol. 2006, 104, 207-214.
159. Capasso R.; Pinto L.; Vuotto M.L.; di Carlo G. Preventive effect of eugenol on PAF and ethanol-induced gastric mucosal damage. Fitoterapia 2000, 71, 131-137.
160. Maity P.; Biswas K.; Roy S.; Banerjee R.K.; Bandyopadhyay U. Smoking and the pathogenesis of gastroduodenal ulcer-recent mechanistic update. Mol. Cel. Biochem. 2003, 253, 329-338.
161. Braquet P.; Etienne A.; Mencia-Huerta J.M.; Clostre F. Effects of the specific platelet-Activating factor antagonists, BN 52021 and BN 52063, on various experimental gastrointestinal ulcerations. Eur. J. Pharmacol. 1988, 150, 269-276.
162. Morsy M.A.; Fouad A.A. Mechanisms of gastroprotective effect of eugenol in indomethacin-induced ulcer in rats. Phytother. Res. 2008, 22, 1361-1366.
163. Souza M.H.L.P.; Lemos H.P.; Oliveira R.B.; Cunha F.Q. Gastric damage and granulocyte infiltration induced by indomethacin in tumour necrosis factor receptor 1 (TNF-R1) or inducible nitric oxide synthase (iNOS) deficient mice. Gut 2004, 53, 791-796.
164. Yoshikawa T.; Naito Y.; Kishi A.; Tomii T.; Kaneko T.; Iinuma S.;
165. Goel R.K.; Bhattacharya S.K. Gastroduodenal mucosal defense and protective agents Indian. J. Exp. Biol. 1991, 29, 701-714.
166. Iwai T.; Ichikawa T.; Goso Y.; Ikezawa T.; Saegusa Y.; Okayasu Y.; Saigenji K.; Ishihara K. Effects of indomethacin on the rat small intestinal mucosa: Immunohistochemical and biochemical studies using anti-mucin monoclonal antibodies. J. Gastroenterol. 2009, 44, 277-284.
167. Jung J.; Lee J.H.; Bae K.H.; Jeong C.S. Anti-gastric actions of eugenol and cinnamic acid isolated from Cinnamoni ramulus. Yakugaku Zasshi 2011, 131, 1103-1110.
168. Marhuenda E.; Martin M.J.; Alarcon De La Lastra C. Antiulcerogenic activity of aescine in different experimental models. Phytother. Res. 1993, 7, 13-16.
169. Yamahara J.; Mochizuki M.; Rong H.Q.; Matsuda H.; Fujimura H. The anti-ulcer effect in rats of ginger constituents. J. Ethnopharmacol. 1988, 23, 299-304.
170. Yang X.; Eilerman R.G. Pungent Principal of Alpinia. galangal (L.) Swartz and Its Applications. J. Agric. Food Chem. 1999, 47, 1657-1662.
171. Nakamura Y.; Murakami A.; Ohto Y.; Torikai K.; Tanaka T.; Ohigashi H. Suppression of tumor promoter-induced oxidative stress and inflammatory responses in mouse skin by a superoxide generation inhibitor 1V-Acetoxychavicol acetate. Cancer Res. 1998, 58, 4832-4839.
172. Kubota K.; Ueda Y.; Yasuda M.; Masuda A. Occurrence and antioxidative activity of 1V-Acetoxychavicol acetate and its related compounds in the rhizomes of Alpinia galanga during cooking. Spec. Publ. R. Soc. Chem. 2001, 274, 601-607.
173. Mitsui S.; Kobayashi S.; Nagahori H.; Ogiso A. Constituents from seeds of Alpinia galanga WILD and their anti-ulcer activies. Chem. Pharm. Bull. 1976, 24, 2377-2382.
174. Matsuda H.; Pongpiriyadacha Y.; Morikawa T.; Ochi M.; Yoshikawa M. Gastroprotective effects of phenylpropanoids from the rhizomes of Alpinia galanga in rats: Structural requirements and mode of action. Eur. J. Pharmacol. 2003, 471, 59-67.
175. Gruenwald J.; Freder J.; Armbruester N. Cinnamon and health. Crit. Rev. Food Sci. Nutr. 2012, 50, 822-834.
176. Leach M.J.; Kumar S. Cinnamon for diabetes mellitus. Cochrane Database Syst. Rev. 2012, 9, doi:10.1002/14651858.CD007170.
177. Keshvari M.; Asgary S.; Jafarian-Dehkordi A.; Najafi S.; Ghoreyshi-Yazdi S.M. Preventive effect of cinnamon essential oil on lipid oxidation of vegetable oil. Atherosclerosis 2013, 9, 280-286.
178. Mereto E.; Brambilla-Campart G.; Ghia M.; Martelli A.; Brambilla G. Cinnamaldehydeinduced micronuclei in rodent liver. Mutat. Res. 1994, 322, 1-8.
179. Shreaz S.; Bhatia R.; Khan N.; Muralidhar S.; Basir S.F.; Manzoor N.; Khan L.A. Spice oil cinnamaldehyde exhibits potent anticandidal activity against fluconazole resistant clinical isolates. Fitoterapia 2010, 82, 1012-1020.
180. Liao J.C.; Deng J.S.; Chiu C.S.; Hou W.C.; Huang S.S.; Shie P.H.; Huang G.J. Anti-inflammatory activities of Cinnamomum cassia constituents in vitro and in vivo. Evid. Based Complement. Altern. Med. 2012, 429320, 1-12.
181. Kim B.H.; Lee Y.G.; Lee J.; Lee J.Y.; Cho J.Y. Regulatory effect of cinnamaldehyde on monocyte/macrophage-mediated inflammatory responses. Mediat. Inflamm. 2010, 2010, 1-9.
182. Wondrak G.T.; Villeneuve N.F.; Lamore S.D.; Bause A.S.; Jiang T.; Zhang D.D. The cinnamon-derived dietary factor cinnamic aldehyde activates the Nrf2-dependent antioxidant response in human epithelial colon cells. Molecules 2010, 15, 3338-3355.
183. El-Bassossy H.M.; Fahmy A.; Badawy D. Cinnamaldehyde protects from the hypertension associated with diabetes. Food Chem. Toxicol. 2011, 49, 3007-3012.
184. Tankam J.M.; Sawada Y.; Ito M. Regular ingestion of Cinnamomi cortex pulveratus offers gastroprotective activity in mice. J. Nat. Med. 2013, 67, 289-295.
185. Harada M.; Yano S. Pharmacological studies on Chinese cinnamon. Effects of cinnamaldehyde on the cardiovascular and digestive systems. Chem. Pharm. Bull. 1975, 23, 941-947.
186. Ali S.M.; Khan A.A.; Ahmed I.; Musaddiq M.; Ahmed K.S.; Polasa H.; Rao L.V.; Habibullah C.M.; Sechi L.A.; Ahmed N. Antimicrobial activities of Eugenol and Cinnamaldehyde against the human gastric pathogen Helicobacter pylori. Ann. Clin. Microbiol. Antimicrob. 2005, 4, 20.
187. Levenstein I. Acute Oral Toxicity Study in Rats and Acute Dermal Toxicity Study in Rabbits; Unpublished Report to Research Institute for Fragrance Materials Inc.: Englewood Cliffs, NJ, USA, 1976.
188. Zaitsev A.N.; Rakhmanina N.L. Toxic properties of pheny-lethanol and cinnamic alcohol derivatives. Vopr. Pitan. 1974, 5, 48-53.
189. Conti B.R.; Búfalo M.C.; Golim M.A.; Bankova V.; Sforcin J.M. Cinnamic acid is partially involved in propolis immunomodulatory action on human monocytes. Evid. Based Complement. Alternat. Med. 2013, 2013, 1-7.
190. Villena J.; Kitazawa H. Modulation of intestinal TLR4-inflammatory signaling pathways by probiotic microorganisms: Lessons learned from Lactobacillus jensenii TL2937. Front. Immunol. 2014, 4, 512.
191. Adisakwattana S.; Sompong W.; Meeprom A.; Ngamukote S.; Yibchok-Anun S. Cinnamic acid and its derivatives inhibit fructose-mediated protein glycation. Int. J. Mol. Sci. 2012, 13, 1778-1789.
192. Furia T.E.; Bellanca N. Fenaroli's Handbook of Flavor Ingredients; Chemical Rubber Company Press: Cleveland, OH, USA, 1975; p. 2.
193. Ress N.B.; Hailey. J.R.; Maronpot R.R.; Bucher J.R.; Travlos G.S.; Haseman J.K., Orzech D.P.; Johnson J.D.; Hejtmancik M.R. Toxicology and carcinogenesis studies of microencapsulated citral in rats and mice. Toxicol. Sci. 2003, 71, 198-206.
194. Ortiz M.I.; Ramírez-Montiel M.L.; González-García M.P.; Ponce-Monter H.A.; Castañeda-Hernández G.; Cariño-Cortés R. The combination of naproxen and citral reduces nociception and gastric damage in rats. Arch. Pharm. Res. 2010, 10, 1691-1697.
195. Derby R.; Rohal P.; Jackson C.; Beutler A.; Olsen C. Novel treatment of onychomycosis using over-The-counter mentholated ointment: A clinical case series. J. Am. Board Fam. Med. 2011, 24, 69-74.
196. Ait-Ouazzou A.; Cherrat L.; Espina L.; Loran S.; Rota C.; Pagan R. The antimicrobial activity of hydrophobic essential oil constituents acting alone or in combined processes of food preservation. Innov. Food Sci. Emerg. 2011, 12, 320-329.
197. Qiu J.Z.; Wang D.C.; Xiang H.; Feng H.H.; Jiang Y.S.A.; Xia L.J. Subinhibitory concentrations of thymol reduce enterotoxins A and B and alpha-hemolysin production in Staphylococcus aureus isolates. PLoS One 2010, 5, e9736.
198. Dhaneshwar S.; Patel V.; Patil D.; Meena G. Studies on synthesis, stability, release and pharmacodynamic profile of a novel diacerein-Thymol prodrug. Bioorg. Med. Chem. Lett. 2013, 23, 55-61.
199. Rintelen B.; Neumann K.; Leeb B.F. A meta-Analysis of controlled clinical studies with diacerein in the treatment of osteoarthritis. Arch. Intern. Med. 2006, 166, 1899-1906.
200. Rainsford K.D. Aspirin and gastric ulceration: Light and electron microscopic observations in a model of aspirin plus stress-induced ulcerogenesis. Br. J. Exp. Pathol. 1977, 58, 215-219.
201. Jung H.W.; Mahesh R.; Park J.H.; Boo Y.C.; Park K.M.; Park Y.K. Bisabolangelone isolated from Ostericum koreanum inhibits the production of inflammatory mediators by down-regulation of NF-kappaB and ERK MAP kinase activity in LPS-stimulated RAW264.7 cells. Int. Immunopharmacol. 2010, 10, 155-162.
202. Wang J.; Zhu L.; Zou K.; Cheng F.; Dan F.; Guo Z.; Cai Z.; Yang J. The antiulcer activities of bisabolangelone from Angelica polymorpha. J. Ethnopharmacol. 2009, 123, 343-346.
203. Kim H.S.; Lee Y.J.; Lee H.K.; Kim J.S.; Park Y.; Kang J.S.; Hwang B.Y.; Hong J.T.; Kim Y.; Han S.B. Bisabolangelone inhibits dendritic cell functions by blocking MAPK and NF-jB signaling. Food Chem. Toxicol. 2013, 59, 26-33.
204. Zhan Y. The Medicinal Source of China Shennongjia; The Science and Technological Press of Hubei: Hubei, China, 1994; pp. 418-419.
205. Fang Z.; Liao Z. The Medicinal Plants from Enshi of Hubei; The Science and Technological Press of Hubei: Hubei, China, 2006; p. 116.
206. Hata K.; Kozawa M.; Ikeshiro Y. On the coumarins of the roots of Angelica polymorpha Maxim. (Umbelliferae). Yakugaku Zasshi 1967, 87, 464-465.
207. Yang Y.; Zhang Y.; Ren F.X.; Yu N.J.; Xu R.; Zhao Y.M. Chemical constituents from the roots of Angelica polymorpha Maxim. Yao Xue Xue Bao. 2013, 48, 718-722.
208. Cai Z.J.; Dan F.J.; Cheng F.; Wang J.Z.; Zou K. Chemical constituents of antibacterial activity fraction of Angelica polymorpha. Zhong Yao Cai 2008, 31, 1160-1162.